![]() |
|
August 4, 2008 | |
MESSAGE FROM THE DIRECTORDear Members: Please click here to continue. ATTENTION CANCER CENTER MEMBERS– Case CCC Retreat SurveyWe would appreciate you taking a short survey about the Cancer Center retreat. We will use your feedback to plan next year's retreat. To take the survey, please click here. All members are encouraged to take the survey, whether or not you attended. We appreciate you taking the time to give us feedback, and are already looking forward to next year! FUNDING OPPORTUNITY– Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)The Cancer Imagine Program of NCI announces a new funding opportunity entitled "Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)". This cooperative agreement mechanism (PAR-08-225) is designed to promote research in quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. To view the announcemnet, please click here. The first date for receipt of applications under this announcement will be October 5, 2008. The Cancer Center would like to organize a response to this announcement. If you are interested, please contact cancer@case.edu as soon as possible. FUNDING OPPORTUNITY– Burroughs Wellcome Fund: Career Awards for Medical ScientistsCWRU SOM has been invited to nominate candidates for the Burroughs Wellcome Fund: Career Awards for Medical Scientists. Institutions may nominate up to FIVE candidates. If a woman or underrepresented minority is nominated within the initial five candidates, a SIXTH candidate may be nominated provided that candidate is a woman or underrepresented minority**. As a direct result of NIH's new K99/R00 Pathway to Independence awards, Burroughs Wellcome Fund now offers the Career Awards for Medical Scientists (CAMS) in lieu of its previous Biomedical Sciences Program. BWF shifted the focus of the CABS program to address the on-going problem of increasing the number of physician scientists and keeping them in research. The Career Awards for Medical Scientists program provides $700,000 over five years to bridge advanced postdoctoral/fellowship training and the early years of faculty service. If you are interested in applying, please send the following documents to Richard.Sohn@case.edu by August 5: For more information about these awards, please click here. FUNDING OPPORTUNITY– Burroughs Wellcome Fund: 2009 Clinical Scientist Awards in Translational Research ProgramCWRU SOM has been invited to nominate candidates for the Burroughs Wellcome Fund: 2009 Clinical Scientist Awards in Translational Research Program. Institutions may nominate up to TWO candidates. EXCEPTIONS: Institutions that nominate a female candidate will be allowed THREE nominations. Institutions that nominate a member of an underrepresented minority group will be allowed a single additional nomination**. The BWF Clinical Scientist Award in Translational Research supports the career development of physician-scientists whose work bridges the gap between basic research and patient care. The program's goal is to foster the development and productivity of established independent physician-scientists who will strengthen translational research through their own studies as well as by mentoring physician-scientist trainees. The awards are intended to give recipients the freedom and flexibility to explore fundamental scientific questions, to apply the resulting knowledge at the bedside, and to bring insights from the clinical setting back to the laboratory for further exploration. BWF is interested particularly in supporting investigators who will bring novel ideas and new approaches to translational research. Large-scale clinical trials, epidemiological or outcome studies, and health services research are not eligible for support. If you are interested in applying, please send the following documents to Richard.Sohn@case.edu by August 6: For more information about these awards, please click here. FUNDING OPPORTUNUTY– AACR Henry Shepard Bladder Cancer Research GrantsThe 2008 AACR Henry Shepard Bladder Cancer Research Grants represent a joint effort of the Henry H. Shepard Trust and the American Association for Cancer Research. These two-year grants will provide up to $250,000 in total support for innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat bladder cancer and/or for pre-clinical research with direct therapeutic intent. Laboratory-based projects must present plans with clinical collaborators indicating how the work will be translated into the clinic. Similarly, clinical studies must show how the work was derived from basic preclinical work and how results will be channeled back to laboratory-based collaborators. Application Deadline: August 25 For more information, please click here. AACR ISSUES CALL FOR IDEAS- Stand Up to CancerAACR invites members of the cancer community to contribute to a groundbreaking effort to accelerate progress against cancer and directly impact patient care. AACR now calls upon members of the cancer community to join this collaborative effort and contribute their ideas to the groundbreaking SU2C Dream Team translational research model. We invite submission of ideas for translational cancer research projects that would address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional Dream Team of expert investigators. The ideas may focus on particular organ sites or on specialized research areas and should be based on perceived opportunities for success as well as high-priority areas with a critical need for rapid progress beyond current medical care. The collective ideas for Dream Team translational research projects suggested by the cancer community will assist the SU2C Scientific Advisory Committee in its deliberations and selection of SU2C Dream Teams. *Please note that in this call for ideas AACR is not accepting research proposals for grant funding. Rather AACR is inviting ideas for SU2C Dream Team translational research projects.* Ideas must be submitted using the instructions and form found on the AACR website by August 20. FUNDING OPPORTUNITY–Junior Investigators: Case CCC ACS IRGThe Case Comprehensive Cancer Center is currently accepting applications for it's American Cancer Society Institutional Research Grant. Pilot funding is available for projects in basic, clinical, behavioral, and epidemiological cancer research with awards up to $30,000 for 1 year cancer research projects that provide the basis for future independent grants. Eligible applicants must: Deadline: August 11 To view application and instructions, please click here. |
EVENTS**All events are open to anyone interested in attending August 4Cancer Genetics/ Biology Journal Club cancelled; will resume late August August 5Taussig Cancer Center Core Curriculum Series Pharmacology and Case CCC Faculty Candidate August 6Grand Rounds August 7Taussig Cancer Center Core Curriculum Series August 8Hematology/Oncology Fellows Seminar more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMS**For more information on these symposiums, please contact Christine Rhoads. Head and Neck Conference ONCOLOGY CONGRESSSeptember 25-28 The Oncology Congress engages you in productive peer-to-peer discussions about cancer prevention, diagnosis, and treatment options, giving you the practical knowledge, tools, and insight needed to improve care and quality of life for your patients today. The Case CCC has partnered with the Oncology Congress to offer a discounted registration rate for Case CCC members: $395 for physicians and $195 for nurses and physician assistants. To register, please click here, and use priority code COE8. MARK YOUR CALENDARS– NanoMedicine Summit 2008September 25-26 The 2008 Cleveland NanoMedicine Summit, is the anchor event for Nano Week in Cleveland (in its fifth year) and will be co-hosted by NorTech's Nano-Network, the Cleveland Clinic Foundation and Case Western Reserve University. This conference has been incredibly successful in the past (as evidenced by national media attention and feedback from attendees) by bringing together scientists, clinicians, business professionals, investors and others to learn, discuss and interact under the umbrella of nanomedicine. The 2008 Summit will focus on the use of nanoparticles for diagnostics and therapeutics. Session highlights include: Many Cancer Center members are involved in this Summit. Drs. James Basilion, Vinod Labhasetwar, and Maciej Zborowski are on the Organizing Committee, and the following members are scheduled to speak: Drs. Stanton Gerson, Clemens Burda, Agata Exner, Vinod Labhasetwar, Horst von Recum, Pam Davis, Mark Cooper, and Thomas Budd. For more information, please click here. |
MARK YOUR CALENDARS– Cancer Research UK Cambridge Research Institute Inaugural Annual SymposiumSeptember 12-13 Please mark your calendars for the Cancer Research UK Cambridge Research Institute's Inaugural Annual Symposium, Unanswered Questions in the Tumour Microenvironment, on September 12-13, 2008 at the Li Ka Shing Centre in Cambridge. The Symposium format has been designed to provide an interactive forum for debate, and to especially encourage discussion of the critical questions and future challenges in tumour microenvironment research. Registration Deadline: August 15 For details, please click here. MARK YOUR CALENDARS– AFAR Conference on Cancer and AgingOctober 6-7 The American Federation on Aging Research (AFAR) is pleased to present Aging and Cancer: Two Sides of the Same Coin?, October 6-7 in New York. This two-day conference will explore fundamental aspects of aging and cancer processes and their interactions. Speakers will examine: genetic and epigenetic changes, environmental influences, and host factors such as oxidative stress and cell death. The evolutionary, cellular and molecular relationships among aging, tumor suppressor mechanisms and the development of cancer as well as the interactions of normal aging cells, stem cells and differences in the manifestation of cancer in young and old will also be discussed. Speakers will report on topics such as telomere biology; nuclear processes such as DNA damage, repair, replication, recombination and transcription; and relevant aspects of mitochondrial structure and function. The goal will be to elucidate genetic and epigenetic alterations that lead to aging and cancer phenotypes. For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESamfAR |
NIH Bulletin – Notices and Funding OpportunitiesReminders Regarding Inclusion of Special Features in Grant Applications (NOT-OD-08-095) Investigational Nutrigenetic Studies for Cancer Prevention (R01) (PA-08-220) Investigational Nutrigenetic Studies for Cancer Prevention (R21) (PA-08-221) Using Systems Science Methodologies to Protect and Improve Population Health (R21) (PAR-08-224) Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) (PAR-08-225) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Green 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.green@uhhospitals.org |
|
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |